You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: January 5, 2025

Patent: 9,359,434


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 9,359,434
Title:Cell culture methods to reduce acidic species
Abstract: The instant invention relates to the field of protein production and purification, and in particular to compositions and processes for controlling the amount of acidic species expressed by host cells, as well as to compositions and processes for controlling the amount of acidic species present in purified preparations.
Inventor(s): Subramanian; Kartik (Northborough, MA), Zeng; Xiaobei (Carolina, PR), Dong; Diane D. (Shrewsbury, MA), Lim; Wen Chung (Worcester, MA), Gifford; Kathreen A. (Marlborough, MA), Chumsae; Christopher (North Andover, MA)
Assignee: AbbVie, Inc. (North Chicago, IL)
Application Number:14/842,933
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 9,359,434
Patent Claims:see list of patent claims
Patent landscape, scope, and claims summary:

Analyzing the Claims and Patent Landscape of United States Patent 9,359,434

Introduction

United States Patent 9,359,434, hereafter referred to as the '434 patent, is a utility patent that was granted by the U.S. Patent and Trademark Office (USPTO). To conduct a comprehensive and critical analysis of its claims and the surrounding patent landscape, it is essential to delve into several key aspects, including the patent's subject matter, the claims themselves, the prior art, and the broader patent landscape.

Understanding the Patent Subject Matter

The '434 patent pertains to a specific invention within a particular technological field. To analyze it effectively, one must first identify the category of the patent. Under U.S. patent law, patents can be categorized into utility, design, or plant patents. Utility patents, like the '434 patent, are granted for new and useful processes, machines, articles of manufacture, or compositions of matter, or any new and useful improvement thereof[5].

Examining the Claims

The claims of a patent are its most critical component, as they define the scope of the invention and the rights granted to the patent holder. Here are some key points to consider:

Claim Structure and Scope

  • The claims should be scrutinized for their clarity, specificity, and breadth. Broad claims may be more susceptible to challenges and litigation, while narrow claims may offer less protection but are generally more defensible.
  • The '434 patent's claims should be analyzed to determine if they meet the criteria of novelty, utility, and non-obviousness, which are the core requirements for patentability under U.S. law[5].

Independent and Dependent Claims

  • Independent claims stand alone and define the invention without reference to other claims. Dependent claims, on the other hand, refer back to and further limit the independent claims.
  • The relationship between independent and dependent claims can affect the overall strength and enforceability of the patent.

Prior Art and Novelty

Prior art refers to all existing knowledge and inventions that predate the filing date of the patent application. To ensure the '434 patent is valid, it must be novel and non-obvious over the prior art.

Conducting a Preliminary Search

  • A thorough search using tools like the USPTO's Patent Public Search, Global Dossier, and other international databases is crucial. These resources help identify existing patents and published patent applications that could be considered prior art[1].

Common Citation Document (CCD)

  • The CCD application can be particularly useful as it consolidates citation data from multiple IP offices, providing a comprehensive view of prior art citations related to the patent family[1].

Patent Landscape Analysis

The patent landscape includes all relevant patents and patent applications in the same technological field. Here are some aspects to consider:

Competitor Patents

  • Identifying patents held by competitors or other entities in the same field can help in understanding the competitive landscape and potential infringement risks.
  • Tools like the USPTO's Patent Public Search and international databases such as the European Patent Office's esp@cenet can be used to find these patents[1].

Patent Assertion Entities (PAEs)

  • PAEs, also known as non-practicing entities, play a significant role in the patent landscape. They can either be Portfolio PAEs, which negotiate licenses for large portfolios, or Litigation PAEs, which primarily file lawsuits to enforce their patents. Understanding the activities of PAEs in the relevant field can provide insights into potential litigation risks and licensing opportunities[3].

Enforcement and Protection

The enforcement and protection of patent rights are critical for the patent holder.

Exclusive Rights

  • Upon the grant of the patent, the holder gains exclusive rights to the production, use, sale, and importation of the patented invention in the United States. This exclusive right is a powerful tool against infringement[5].

Litigation and Appeals

  • If disputes arise, the patent holder can seek redress through federal courts. The USPTO's Patent Trial and Appeal Board (PTAB) also provides a venue for appealing final rejections or challenging the validity of issued patents[5].

Impact of AI on Patent Applications

With the increasing use of AI tools in patent drafting and prosecution, it is important to consider their impact on the '434 patent.

Disclosure Requirements

  • If AI tools were used in the drafting of the patent application or in contributing to the invention, this must be disclosed to the USPTO. Failure to disclose material information regarding AI contributions can affect the validity of the patent[2].

Inventorship and Contributions

  • The role of AI in the inventive process must be carefully assessed to ensure that the contributions made by natural persons meet the criteria for inventorship. This is crucial for maintaining the integrity and validity of the patent[2].

Key Takeaways

  • Claims Analysis: The claims of the '434 patent must be clear, specific, and meet the criteria of novelty, utility, and non-obviousness.
  • Prior Art: A thorough search of prior art is essential to ensure the patent's validity.
  • Patent Landscape: Understanding the competitive landscape, including competitor patents and PAE activities, is vital for strategic planning.
  • Enforcement: The exclusive rights granted by the patent must be enforced through legal means if necessary.
  • AI Impact: The use of AI tools in patent drafting and prosecution must be disclosed and carefully managed to avoid validity issues.

FAQs

Q: What is the primary purpose of conducting a preliminary patent search? A: The primary purpose is to identify existing patents and published patent applications that could be considered prior art, ensuring the novelty and non-obviousness of the invention.

Q: How do Patent Assertion Entities (PAEs) impact the patent landscape? A: PAEs can significantly impact the patent landscape through either negotiating licenses for large portfolios (Portfolio PAEs) or filing lawsuits to enforce their patents (Litigation PAEs), affecting both licensing opportunities and litigation risks.

Q: What are the implications of using AI tools in patent applications? A: Using AI tools requires disclosure to the USPTO if the AI contributions are material to patentability. Additionally, the role of AI in the inventive process must be carefully assessed to ensure that natural persons meet the criteria for inventorship.

Q: What are the different types of patents under U.S. patent law? A: Under U.S. patent law, patents can be categorized into utility patents, design patents, and plant patents, each offering different types of legal protection.

Q: How can a patent holder enforce their exclusive rights? A: A patent holder can enforce their exclusive rights through federal courts by initiating civil actions against parties accused of making, using, or selling the patented invention without authorization.

Sources

  1. USPTO - Search for patents: https://www.uspto.gov/patents/search
  2. BIPC - U.S. Patent Office Issues Additional Guidance on Use of AI Tools: https://www.bipc.com/united-states-patent-office-issues-guidance-on-use-of-ai-tools
  3. FTC - Patent Assertion Entity Activity: An FTC Study: https://www.ftc.gov/system/files/documents/reports/patent-assertion-entity-activity-ftc-study/p131203_patent_assertion_entity_activity_an_ftc_study_0.pdf
  4. U.S. Department of Commerce - U.S. Patent and Trademark Office: https://www.commerce.gov/bureaus-and-offices/uspto
  5. APU - What Is a Patent Law - And Why Does It Matter?: https://www.apu.apus.edu/area-of-study/security-and-global-studies/resources/what-is-patent-law/

More… ↓

⤷  Subscribe

Details for Patent 9,359,434

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Abbvie Inc. HUMIRA adalimumab Injection 125057 December 31, 2002 ⤷  Subscribe 2032-04-20
Abbvie Inc. HUMIRA adalimumab Injection 125057 February 21, 2008 ⤷  Subscribe 2032-04-20
Abbvie Inc. HUMIRA adalimumab Injection 125057 April 24, 2013 ⤷  Subscribe 2032-04-20
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.